Does Longitudinal Nursing Follow-up Improve Smoking Cessation in Patients Referred for COPD Screening
NCT ID: NCT05577767
Last Updated: 2025-09-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
233 participants
OBSERVATIONAL
2020-09-11
2026-09-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Smoking Cessation in Primary Health Care Patients With Obstructive Pulmonary Disease
NCT01072422
The Effects of a Self-management Intervention on Low Literacy Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT01327456
Impact of Twice-daily Measurement of Expired CO During Hospitalization on Smoking
NCT03729063
Medication Adherence in COPD--A Self-Regulation Study
NCT00005717
Informational Tool for Smoking Cessation in COPD Patients
NCT06872450
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
we proposed to evaluate if a longitudinal nursing follow-up at 3 months, 6 months and one year, in patients coming to screening for COPD.
Cessation of respiratory toxics is the most effective intervention in stopping the progression of COPD.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Read, write and understand the French language
* Patient affiliated to a social security system
* Written and signed informed consent
Exclusion Criteria
* Patients receiving inhaled respiratory therapy
* Persons unable to perform spirometry
* Pregnant women
* Refusal to participate in research
* Patient under guardianship, deprived of liberty, safeguard of justice
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier de Valence
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gilles RIVAL, MD
Role: PRINCIPAL_INVESTIGATOR
CH VALENCE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ch Valence
Valence, Drome, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RIPH-CHV-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.